---
id: plague_063
category: organisms
tags: [plague, yersinia-pestis, bubonic, pneumonic, bioterrorism, gentamicin, doxycycline]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Plague (Yersinia pestis) - Bioterrorism Agent

**Q:** What are the clinical forms of plague, their presentations, and treatment including bioterrorism scenarios?

**A:**

**Microbiology:**
- **Gram-negative coccobacillus** ("safety pin" bipolar staining with Wayson stain)
- **Yersinia pestis**
- Virulence factors: Capsular F1 antigen, Yersinia outer proteins (Yops)

**Epidemiology:**
- **Zoonotic:** Rodents (prairie dogs, squirrels, rats) → fleas → humans
- **US:** ~7 cases/year (Southwest: New Mexico, Arizona, Colorado)
- **CDC Category A bioterrorism agent**
- Historical: "Black Death" (14th century) killed 1/3 of Europe

---

**Clinical Forms:**

**1. Bubonic Plague (85% of cases):**

**Transmission:** Flea bite (Xenopsylla cheopis)

**Incubation:** 2-8 days (average 2-4 days)

**Clinical Presentation:**
- **Sudden onset fever, chills, headache, malaise**
- **Painful lymphadenopathy** (bubo) within 24h of fever onset
  - **Bubo:** Extremely tender, swollen lymph node (1-10 cm)
  - Location: Inguinal (most common), axillary, cervical (depends on flea bite site)
  - **Skin overlying bubo:** Erythematous, warm
- **Severe systemic toxicity** (out of proportion to local findings)
- Bacteremia develops in 25% → septicemic plague

**Key Feature:** **Painful bubo + acute febrile illness + flea/rodent exposure**

**Prognosis:**
- **Mortality <5% with treatment**, 40-60% untreated

**2. Septicemic Plague (10-25% of cases):**

**Two Forms:**
- **Primary septicemic:** Bloodstream infection without bubo (no bubo develops)
- **Secondary septicemic:** Progression from bubonic

**Clinical Presentation:**
- **Severe sepsis/septic shock**
- **DIC** (disseminated intravascular coagulation)
- **Purpura, acral necrosis** (digits, nose, ears) → "Black Death"
- **Multi-organ failure**
- **No bubo** (if primary septicemic)

**Prognosis:**
- **Mortality 30-50% with treatment**, near 100% untreated

**3. Pneumonic Plague (Bioterrorism Scenario):**

**Transmission:**
- **Primary:** Inhalation of aerosolized Y. pestis (bioterrorism) or droplet from another pneumonic patient
- **Secondary:** Hematogenous spread from bubonic/septicemic plague

**Incubation:** 1-3 days (very rapid)

**Clinical Presentation:**

**Acute Fulminant Pneumonia:**
- **Sudden onset high fever, chills**
- **Severe respiratory distress, dyspnea**
- **Productive cough with hemoptysis** ("blood-tinged watery sputum")
- **Chest pain**
- **Gastrointestinal symptoms:** Nausea, vomiting, abdominal pain
- **Rapid progression to respiratory failure** (24-48h)

**Imaging:**
- **Bilateral infiltrates** (patchy or consolidation)
- **Pleural effusions**
- **Mediastinal lymphadenopathy**

**Prognosis:**
- **Nearly 100% fatal if not treated within 18-24 hours**
- **Mortality 50% even with early treatment**

**Key Feature:** **Person-to-person transmission** (droplet)
- **High bioterrorism potential**
- Requires respiratory isolation

**4. Pharyngeal Plague (Rare):**
- Ingestion of contaminated meat
- Cervical lymphadenitis, pharyngitis
- Can progress to septicemia

---

**Diagnosis:**

**Specimens:**
- **Bubo aspirate** (bubonic): Gram stain, culture
- **Blood cultures** (always obtain)
- **Sputum** (pneumonic): Gram stain (bipolar "safety pin" rods), culture
- **Pleural fluid**

**Rapid Tests:**
- **F1 antigen detection** (rapid)
- **PCR**

**Key Lab Findings:**
- Gram-negative coccobacilli with **bipolar staining** ("safety pin")
- Culture: Slow growth (24-48h), requires biosafety level 3

---

**Treatment:**

**Key Principle:** **Start antibiotics IMMEDIATELY upon suspicion** (do NOT wait for confirmation)
- Pneumonic plague: Nearly 100% fatal if treatment delayed >18-24h

**1. First-Line Treatment (CDC 2024 Recommendations):**

**Preferred:**

| **Antibiotic** | **Dosing** | **Duration** |
|----------------|------------|--------------|
| **Gentamicin** (preferred) | 5 mg/kg IV/IM q24h (or 2 mg/kg load, then 1.7 mg/kg q8h) | 10-14 days |
| **Doxycycline** | 100 mg IV/PO q12h | 10-14 days |

**Alternative Fluoroquinolones:**
| **Antibiotic** | **Dosing** | **Duration** |
|----------------|------------|--------------|
| **Levofloxacin** | 750 mg IV/PO q24h | 10-14 days |
| **Ciprofloxacin** | 400 mg IV q8-12h (or 500-750 mg PO BID) | 10-14 days |
| **Moxifloxacin** | 400 mg IV/PO q24h | 10-14 days |

**Notes:**
- **Gentamicin + doxycycline:** Both first-line (aminoglycoside + tetracycline)
- **Streptomycin** (historical drug of choice) - less available, use gentamicin
- Fluoroquinolones have excellent efficacy (FDA-approved)

**2. Treatment by Form:**

**Bubonic/Septicemic:**
- Gentamicin OR fluoroquinolone OR doxycycline
- Monotherapy acceptable

**Pneumonic (Including Bioterrorism):**
- **Gentamicin** (preferred)
- Alternative: Fluoroquinolone or doxycycline
- Some experts recommend **combination therapy** (aminoglycoside + fluoroquinolone or doxycycline) for severe cases

**Meningitis (Rare):**
- **Chloramphenicol** (best CNS penetration) - if available
- Alternative: Fluoroquinolone (levofloxacin, moxifloxacin)

**3. Pediatric Dosing:**
- Gentamicin: 2.5 mg/kg IV/IM q8h
- Doxycycline: Use in children despite age (life-threatening infection)
  - <45 kg: 2.2 mg/kg IV/PO q12h
  - ≥45 kg: Adult dosing

---

**Post-Exposure Prophylaxis (PEP) - Bioterrorism:**

**Indications:**
- Close contact (<2 meters) with pneumonic plague patient
- Laboratory exposure

**Regimen (7 days):**

| **Antibiotic** | **Dosing** |
|----------------|------------|
| **Doxycycline** (preferred) | 100 mg PO BID x 7 days |
| **Ciprofloxacin** | 500 mg PO BID x 7 days |
| **Levofloxacin** | 750 mg PO daily x 7 days |

---

**Infection Control:**

**Bubonic/Septicemic:** Standard precautions

**Pneumonic:**
- **Droplet precautions** (person-to-person transmission possible)
- Respiratory isolation until **48 hours of antibiotics**
- N95 mask for healthcare workers
- **Report immediately** to public health

---

**Bioterrorism Scenario:**

**Aerosolized Y. pestis:**
- Primary pneumonic plague (no buboes)
- Incubation 1-3 days
- **Sudden surge of severe pneumonia cases** with hemoptysis
- Rapid progression to respiratory failure
- Person-to-person spread → epidemic potential

**Response:**
- Mass PEP (doxycycline or ciprofloxacin x 7 days)
- Respiratory isolation
- Immediate antibiotic treatment (gentamicin or fluoroquinolone)

---

**Comparison: Bubonic vs Pneumonic Plague**

| **Feature** | **Bubonic** | **Pneumonic** |
|-------------|-------------|---------------|
| **Transmission** | Flea bite | **Aerosolized/droplet** |
| **Incubation** | 2-8 days | 1-3 days (rapid) |
| **Key finding** | **Painful bubo** | **Hemoptysis** |
| **Person-to-person** | ❌ No | ✅ **Yes** (droplet) |
| **Mortality (treated)** | <5% | 50% |
| **Bioterrorism risk** | Low | ✅ **High (Category A)** |
| **Isolation** | Standard precautions | **Droplet precautions** |

---

**Mnemonic: "PLAGUE = Painful Lymph Adenopathy, Get Urgent Empiric Rx"**
- **P**ainful bubo (bubonic)
- **L**ymph adenopathy (extremely tender)
- **A**minosglycosides (gentamicin first-line)
- **G**ram-negative rod ("safety pin")
- **U**rgent treatment (pneumonic → 100% fatal if delayed)
- **E**mpire treatment (do NOT wait for confirmation)

**Mnemonic: "Pneumonic Plague = Pneumonia + Hemoptysis, Person-to-person"**
- **P**neumonia (bilateral infiltrates)
- **H**emoptysis (blood-tinged sputum)
- **P**erson-to-person (droplet transmission)

**Clinical Pearls:**
- **Bubonic plague: Painful bubo + acute fever + flea/rodent exposure** (Southwest US)
- **Pneumonic plague: Hemoptysis + fulminant pneumonia + rapid progression** (bioterrorism concern)
- **Start antibiotics IMMEDIATELY** upon suspicion (pneumonic → 100% fatal if delayed >24h)
- **Gentamicin or fluoroquinolone** first-line (streptomycin less available)
- **Doxycycline also first-line** (randomized trial showed equivalence to gentamicin)
- **Pneumonic plague requires droplet precautions** (person-to-person transmission)
- **Bioterrorism clue:** Sudden surge of pneumonic plague cases (does NOT occur naturally in US)
- **PEP for close contacts:** Doxycycline or ciprofloxacin x 7 days
- **"Safety pin" bipolar staining** on Gram stain (Wayson stain)
- Historical "Black Death" due to purpura, acral necrosis from DIC

**Media:** None

**Sources:** [CDC MMWR 2021 - Plague antimicrobial treatment], [CDC 2024 - Plague clinical care], [Medscape 2024 - Plague guidelines], [WHO 2024 - Antibiotics for plague], [CID 2006 - Treatment of plague], [Merck Manual 2024 - Plague], [PMC 2011 - Comparative efficacy antibiotics]
